BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
The Company continues its progression towards a Nasdaq uplisting POMPANO BEACH, FL, March 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its […]
The post BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025 first appeared on Prism Media Wire.
